De stand van zaken m.b.t. de grondige hervorming van de Commissie Tegemoetkoming Geneesmiddelen

This procedure concerns an update on the progress of a significant reform within the Commission responsible for the reimbursement of medicines. It aims to provide transparency on the ongoing changes. This update affects patients, healthcare providers, and pharmaceutical companies by detailing changes to how medicines are approved for reimbursement and their associated costs.